We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.2B
AUM Growth
-$730M
Cap. Flow
-$164M
Cap. Flow %
-5.14%
Top 10 Hldgs %
14.44%
Holding
1,433
New
85
Increased
447
Reduced
621
Closed
196

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$7.65M
2
VZ icon
Verizon
VZ
+$4.92M
3
LIN icon
Linde
LIN
+$4.78M
4
ILMN icon
Illumina
ILMN
+$4.5M
5
AAPL icon
Apple
AAPL
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 13.46%
2 Technology 12.76%
3 Financials 11.37%
4 Industrials 8.31%
5 Consumer Discretionary 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DISCK
201
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3.58M 0.11%
155,217
+785
+0.5% +$21.8K
WAB icon
202
Wabtec
WAB
$49.3B
$3.58M 0.11%
50,888
+2,578
+5% +$225K
SNPS icon
203
Synopsys
SNPS
$79.7B
$3.57M 0.11%
42,390
+1,308
+3% +$116K
XLV icon
204
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
$3.57M 0.11%
41,270
-1,940
-4% -$176K
NKE icon
205
Nike
NKE
$61.9B
$3.55M 0.11%
47,918
+6,157
+15% +$461K
EXPD icon
206
Expeditors International
EXPD
$23.2B
$3.55M 0.11%
52,124
-1,530
-3% -$107K
IGV icon
207
iShares Expanded Tech-Software Sector ETF
IGV
$14.7B
$3.46M 0.11%
99,615
-775
-0.8% -$28.1K
VGLT icon
208
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
$3.45M 0.11%
+46,135
New +$3.29M
VOD icon
209
Vodafone
VOD
$37.4B
$3.44M 0.11%
178,677
+7,998
+5% +$160K
CL icon
210
Colgate-Palmolive
CL
$74.4B
$3.44M 0.11%
57,781
-1,218
-2% -$76.2K
RIO icon
211
Rio Tinto
RIO
$164B
$3.42M 0.11%
70,467
+1,787
+3% +$87.2K
XYZ
212
Block Inc
XYZ
$47.5B
$3.38M 0.11%
60,195
+3,017
+5% +$213K
CTSH icon
213
Cognizant
CTSH
$26B
$3.37M 0.11%
53,038
-14,896
-22% -$1.04M
IYC icon
214
iShares US Consumer Discretionary ETF
IYC
$1.23B
$3.34M 0.1%
73,772
-2,132
-3% -$104K
MNDT
215
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.31M 0.1%
203,877
+7,666
+4% +$138K
GS icon
216
Goldman Sachs
GS
$303B
$3.3M 0.1%
19,754
-21,111
-52% -$4.26M
NEM icon
217
Newmont
NEM
$119B
$3.29M 0.1%
94,918
+7,924
+9% +$257K
BIIB icon
218
Biogen
BIIB
$30.7B
$3.28M 0.1%
10,887
-13
-0.1% -$4.15K
FE icon
219
FirstEnergy
FE
$27.5B
$3.26M 0.1%
86,765
-4,404
-5% -$167K
RSP icon
220
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$3.25M 0.1%
35,609
-1,394
-4% -$138K
NVS icon
221
Novartis
NVS
$297B
$3.23M 0.1%
42,031
+1,117
+3% +$86.9K
SO icon
222
Southern Company
SO
$107B
$3.21M 0.1%
73,208
-726
-1% -$33K
GSK icon
223
GSK
GSK
$106B
$3.2M 0.1%
67,077
-14,392
-18% -$709K
APU
224
DELISTED
AmeriGas Partners, L.P.
APU
$3.19M 0.1%
126,078
-67,870
-35% -$2.36M
IDXX icon
225
Idexx Laboratories
IDXX
$46.2B
$3.18M 0.1%
17,113
+14,430
+538% +$2.96M

Similar funds

Oppenheimer & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Oppenheimer & Co held 1,433 positions worth $3.2B, down 19% from $3.93B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $164M in Q4 2018, closing 196 positions and reducing 621 holdings. Its most notable exit was Etsy, an estimated $6.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Oppenheimer & Co opened a new position in Linde worth $4.72M.

  • Oppenheimer & Co's largest Q4 2018 buy was Linde: 30,256 shares worth $4.72M.
  • Oppenheimer & Co added most to iShares 20+ Year Treasury Bond ETF in Q4 2018, an estimated $7.65M increase.
  • Oppenheimer & Co's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $9.23M.
  • Oppenheimer & Co fully exited Etsy in Q4 2018, selling an estimated $6.87M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.2B portfolio in Q4 2018.
  • Oppenheimer & Co opened 85 new positions and closed 196 in Q4 2018.
  • Oppenheimer & Co's portfolio value fell 19% quarter-over-quarter to $3.2B.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.